<i>CYP2D6</i> Genotype-Based Dose Recommendations for Risperidone in Asian People.

Front Pharmacol · 2020 · PMC7417932 · PMID 32848719

Europe PMC DOI

hedged sentence

0.0300

closest p · 0.6× alpha

0.0300

boldest claim

The sentences

nominally significantp=0.03actually significant

In addition, when comparing poor metabolizers (PM) with NM, the same trend was observed and nominally significant differences were found in the Css/dose (mean difference[90% CI]:- 7.17[-13.48,-0.87], p=0.03) and AUC/dose (mean difference[90% CI]:-19.85[-36.69,-3.01], p=0.02).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.